Researchers have used large-scale virtual compound libraries, in silico screening and computer simulations to identify small ...

Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified endpoint The reduction in GluSph in CSF, a first-ever ...

Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Addex Therapeutics amends its ATM agreement with HC Wainwright & Company: Geneva, Switzerland Friday, December 12, 2025, 14:30 Hrs [IST] Addex Therapeutics, a clinical-stage bioph ...

New analysis examines RAP-219’s effect during the first month of treatment and consistency of efficacy over the treatment ...

Addex is not obligated to make any sales of ADSs under the ATM Agreement. The Company or H.C. Wainwright & Co. may suspend or ...

The latest announcement is out from Addex Therapeutics ( (CH:ADXN) ).

The authors present a set of wrappers around previously developed software and machine-learning toolkits, and demonstrate their use in identifying endogenous sterols binding to a GPCR. The resulting ...

Q3 2025 Earnings Call Transcript December 4, 2025 Operator: Good day, and thank you for standing by. Welcome to the Addex Therapeutics Third Quarter 2025 Financial Results and Corporate Update ...